Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Psoriasis, Date of authorisation: 17/09/2018, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Psoriasis, Date of authorisation: 17/09/2018, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Lantus, insulin glargine, Diabetes Mellitus, Date of authorisation: 09/06/2000, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR): Lantus, insulin glargine, Diabetes Mellitus, Date of authorisation: 09/06/2000, Revision: 40, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.